Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today authorized 23andMe's genetic health risk report for three BRCA1 and BRCA2 mutations most commonly found in people of Ashkenazi Jewish descent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.